Beauty Health terminates CRO Daniel Watson without cause; $430K severance, RSU acceleration

SkinHealth Systems Inc.

Chief Revenue Officer Daniel Watson terminated without cause effective Oct 14, 2024; advisory role through Jan 1, 2025.
Receives $430K cash severance over 12 months, plus accelerated vesting of 329,251 RSUs.
Will serve as consultant Jan-Mar 2025 at $40K/month; non-compete through March 2026.
Separation Agreement filed; Watson releases all claims against the company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel Watson

Chief Revenue Officer

SKIN · SkinHealth Systems Inc.

Effective: 2024-10-14
Filed: November 12, 2024, 6:59 PM ET

On October 8, 2024, the Board of Directors of the Company terminated Daniel Watson’s employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024 (the "Termination Date").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Watson was terminated as Chief Revenue Officer at SkinHealth Systems Inc..

Action: terminated
Role: Chief Revenue Officer

Exact text from the filing

On October 8, 2024, the Board of Directors of the Company terminated Daniel Watson’s employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024 (the "Termination Date").

View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-047098

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.